The prevention revolution written in your DNA

An ounce of prevention is worth a pound of cure. Benjamin Franklin said it in 1736. Preventing disease is the best cure, and genomics has always held extraordinary promise. Now it's delivering on it. Together, Genomics and Gene by Gene have joined forces to roll out a genuine first. Polygenic risk score-guided screening alone across seven of the most common diseases, from cardiovascular disease to breast cancer to diabetes, could reduce premature deaths in high-risk groups by 23.3%. And that's before you add in pharmacogenomics. Join Josh Wittner, President of Gene by Gene; David Thornton, President of Genomics; Dr Rebecca Rohrer, Clinical Innovation and Genomics Director at Bupa; and Sandosh Padmanabhan, Pontecorvo Chair of Pharmacogenomics, on the Main Stage at HLTH Europe.